Skip to content

Comparison of the effect of promethazine and diazepam on the treatment of peripheral vertigo

Comparison of the effect of intravenous promethazine and diazepam on the reduction of peripheral true vertigo symptom among the patient admitted to the emergency ward in Shahid Mohammadi hospital

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061210330N2
Enrollment
154
Registered
2017-06-26
Start date
2017-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertigo. Dizziness and giddiness

Interventions

Intervention 1: Diazepam is an injection of 10 mg should be dissolved in 100 ml of normal saline solution a infusion within 20 -30 minutes. Intervention 2: Promethazine an injection of 25 mg should be
Treatment - Drugs
Diazepam is an injection of 10 mg should be dissolved in 100 ml of normal saline solution a infusion within 20 -30 minutes.
Promethazine an injection of 25 mg should be dissolved in 100 ml of normal saline solution a infusion within 20 -30 minutes.

Sponsors

Hormozgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of study :patients admitted to Shahid Mohammadi hospital with true vertigo; patients admitted to Shahid Mohammadi hospital over 18 years old and less than 70 years old;patients who do not intake anti-vertigo drugs before comming to hospital. Exclusion criteria: pregnant women; individual who suffer from know drug's allergy; people who drink alcohol; patients who feel vertigo by using drugs; patients who suffer from advanced liver disease; patients who need to follow up with more checks.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of vertigo. Timepoint: At the start of study and 30 minutes after prescription. Method of measurement: The visual and verbal questionnaire.

Secondary

MeasureTime frame
Vomiting. Timepoint: the start of study-30 minutes after Prescription. Method of measurement: the visual and verbal questionare.;Ataxia. Timepoint: the start of study-30 minutes after Prescription. Method of measurement: the visual and verbal questionare.;Nystagmus. Timepoint: the start of study-30 minutes after Prescription. Method of measurement: the visual and verbal questionare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Ashkan Tabibzade

Hormozgan University of Medical Sciences

dr.tabib52@gmail.com+98 763337192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026